Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is It Time to Buy the Nasdaq's 6 Worst-Performing June Stocks?
Is It Time to Buy the Nasdaq's 6 Worst-Performing June Stocks?

The Nasdaq 100 index delivered another great month for investors in June, but some stocks in the index didn't enjoy that growth. A handful of Nasdaq stocks fell in price while the index climbed.

1 Big Reason to Buy Snowflake Stock Right Now
1 Big Reason to Buy Snowflake Stock Right Now

Even after almost a year since its IPO and down some 30% in price from where it was in initial public trading, Snowflake (NYSE: SNOW) remains one of the most notoriously "expensive" stocks out

Lockheed Martin's F-35 Wins Swiss Fighter Dogfight
Lockheed Martin's F-35 Wins Swiss Fighter Dogfight

Lockheed Martin's (NYSE: LMT) F-35 fighter has beaten out rivals from Boeing (NYSE: BA) and Airbus (OTC: EADSY), among others, to capture a $6.5 billion order from Switzerland. The deal is a

Why Is Everyone Talking About Nano-X Stock?
Why Is Everyone Talking About Nano-X Stock?

Nano-X Imaging (NASDAQ: NNOX) is creating a lot of heat these days -- the stock is down 27% this year but up more than 33% over the past month. That's particularly ironic because the company's

3 Huge Investing Mistakes to Avoid in Your 60s
3 Huge Investing Mistakes to Avoid in Your 60s

Your 60s are a pivotal time in life. During your 60s, you may be wrapping up your career and getting ready to kick-start the retirement of your dreams

But be careful -- the wrong investing

1 Tech Stock Positioned to Perform Well During Inflation
1 Tech Stock Positioned to Perform Well During Inflation

The coronavirus was a big boost to Docusign's (NASDAQ: DOCU) e-signature platform as businesses scrambled to continue operating in a remote environment. As the pandemic slowly becomes something in

Electronic Arts Is Igniting Its Mobile Growth, but Investors Don't Care
Electronic Arts Is Igniting Its Mobile Growth, but Investors Don't Care

Shares of Electronic Arts (NASDAQ: EA) are currently flat on the year and trailing the S&P 500's return of 14.3%. But EA is putting some serious cash to work to expand its gaming empire, and it

Why I Love Shopify's Business Model
Why I Love Shopify's Business Model

Shopify (NYSE: SHOP) is widely known for providing an e-commerce platform for merchants, but that's not all investors need to know. In this Fool Live clip, recorded on June 23, Fool.com contributor

3 Reasons to Invest in Crypto -- and 1 Reason Not to
3 Reasons to Invest in Crypto -- and 1 Reason Not to

Cryptocurrency is gaining broader adoption among investors these days. Fintech companies are making it easier to get started buying and using crypto; companies like Tesla have experimented with

My Favorite Bank Stock to Beat Inflation
My Favorite Bank Stock to Beat Inflation

Owning bank stocks is a great way to hedge against inflation, as this industry tends to thrive during inflationary periods. But there's one banking stock that may be a better bet than others. On a

Did Citizens Financial Group Cost Its Shareholders by Sitting Out the Fed's Stress Testing?
Did Citizens Financial Group Cost Its Shareholders by Sitting Out the Fed's Stress Testing?

I remain bullish on Citizens Financial Group (NYSE: CFG) and, in particular, the unique digital consumer bank it's building. But after seeing the recently revealed results of the Federal Reserve's

Is a Bigger Shake-Up at GlaxoSmithKline on the Way?
Is a Bigger Shake-Up at GlaxoSmithKline on the Way?

GlaxoSmithKline (NYSE: GSK) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic

1 Reason to Use Coinbase's New 4% Savings Account, 1 Big Reason Not to
1 Reason to Use Coinbase's New 4% Savings Account, 1 Big Reason Not to

Believe it or not, there used to be a time when one could actually earn decent returns in a bank savings account. But these days, we are in an era of extraordinarily low interest rates. The national

How Risky Is Ocugen After Its Recent Setback?
How Risky Is Ocugen After Its Recent Setback?

Investors cheered on Ocugen (NASDAQ: OCGN) earlier this year when it signed a deal to co-commercialize Bharat Biotech's vaccine candidate in the U.S. The company recently abandoned the idea of a

4 Ways to Score an Even Bigger Social Security Check
4 Ways to Score an Even Bigger Social Security Check

Millions of seniors today depend on Social Security to pay the bills and serve as a key source of retirement income. If you're eager to eke more money out of the program, here are a few ways to pull

1 Mall Stock That's Actually Worth Buying
1 Mall Stock That's Actually Worth Buying

Many investors are reluctant to go anywhere near brick-and-mortar retail, especially malls. And it's not surprising: After all, many mall-based retailers were struggling before the pandemic hit

This is Novavax's Biggest Challenge Right Now
This is Novavax's Biggest Challenge Right Now

Novavax (NASDAQ: NVAX) is readying itself for the potential launch of its coronavirus vaccine candidate. The company has built out a significant manufacturing network. But the path hasn't been

NBA Viewership Is Up: Why That's Good News for Disney
NBA Viewership Is Up: Why That's Good News for Disney

Walt Disney (NYSE: DIS) has just gone through a devastating 15 months. The coronavirus pandemic forced it to temporarily close its doors on theme parks, resorts, cruise ships, and shops.

This time

3 Value Stocks That'll Make You Richer in July (and Beyond)
3 Value Stocks That'll Make You Richer in July (and Beyond)

For more than 12 years, Wall Street and investors have been enamored with growth stocks. That's because historically low lending rates and abundant access to capital created the perfect environment

Is the U.S. Buying Too Many COVID Vaccine Doses?
Is the U.S. Buying Too Many COVID Vaccine Doses?

The U.S. government began securing supply deals with COVID-19 vaccine makers in 2020. It's still buying more vaccines this year, with the total doses ordered more than enough to vaccinate every

How to Manage Your 401(k) Without Lifting a Finger: https://g.foolcdn.com/assets/images/fool/tmf-logo_400x400.png
How to Manage Your 401(k) Without Lifting a Finger

There is a belief in the broader personal finance community that investing for retirement is a complicated dance that only a few people are able to figure out. Accompanying this belief is the idea

Why SoFi's Leadership Is a Strength
Why SoFi's Leadership Is a Strength

A management team can make or break the long-term success of an investment. It's good to have a great value proposition or an aspirational mission statement, but if leadership can't execute, then it

Why Dynavax Stock Has Jumped 11% So Far This Week
Why Dynavax Stock Has Jumped 11% So Far This Week

Shares of Dynavax Technologies (NASDAQ: DVAX) were up by 11.2% so far this week as of the market close on Thursday. That gain was primarily due to the company's announcement on Wednesday that it had

Can Novavax Beat Moderna and Pfizer in Preventing Severe COVID?
Can Novavax Beat Moderna and Pfizer in Preventing Severe COVID?

Preventing severe cases of coronavirus has been a major goal of vaccination campaigns. That's because these cases put individuals at a higher risk for hospitalization or even death. In this Motley

Better Short-Squeeze Stock: Clover Health or Ocugen?
Better Short-Squeeze Stock: Clover Health or Ocugen?

Make a lot of money. That's the goal of every investor. The simplest way that gives you the best chances of making money is buying great stocks and holding them for a long time. However, some prefer